Pharma Issues

Companies in the pharmaceutical industry are also looking to implement value based purchasing but will face challenges in estimating an appropriate time-frame for manufacturers to demonstrate drug efficacy. Therefore, it will be difficult for new drugs to compete in the value-based payment system.

The most prominent issues reported are drug safety, pricing, data disclosure, importation, clinical study design, marketing restrictions, DTC advertising, animal testing, internationalmarket, developing countries, issues related to vaccines, growth of drug counterfeiting, the cost effectiveness of treatments, and in …

Challenges for the Indian pharmaceutical industry

  • A lack of a stable pricing and policy environment. …
  • Lack of capabilities in the innovation space. …
  • External markets. …
  • The US generics market. …
  • Quality compliance scrutiny.

6 Critical Risks Facing the Pharmaceutical Industry

  • 1) Increased Competition from Generic Drugs. In 2017, the FDA began a push to get lower-cost generic drugs out to market faster. …
  • 2) Legal Liability for Opioid Addiction. …
  • 3) Product Liability. …
  • 4) Keeping Up with Technology. …
  • 5) Counterfeit Drugs and Global Quality Control. …
  • 6) Patent Cliffs.

Effective for Global Trends

PharmaIssues.com is for sale!

– Selling on DAN.com –